Chart Of The Day: Pfizer's Shot At An Upside Move May Just Have Fizzled

 | Jan 20, 2021 01:38

When 23 elderly Norwegians died recently, after receiving the Pfizer (NYSE:PFE) COVID-19 vaccine, China's Communist Party tabloid The Global Times slowing its deliveries to Europe, as it aims to ramp up production. We can't say whether this last development is related to any internal issues regarding quality control at the company as well, or whether logistics alone are the cause.

However, Michigan's Wayne County, where Detroit is located, just announced it was shifting to the Moderna (NASDAQ:MRNA) vaccine, citing supply shortages of the Pfizer innoculation. Will Pfizer lose business to Moderna, because of the production slowdown? We couldn't say.

But the supply-demand balance on PFE's technical chart has been tilting toward a selloff.